PS

Parmjit Singh Walia

Active Director Director DIN 10478418
DIN 10478418 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Parmjit Singh Walia

Data last updated:

Parmjit Singh Walia is a Director at Yashu Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Yashu Pharmaceuticals Private Limited reported revenue of ₹3.22 Cr (FY 2021).

DIN 10478418
Primary Designation Director
Industry Pharma
First Appointment 25 Jan 2024
Oldest Company Age 16 yrs
Largest company Yashu Pharmaceuticals Private Limited · ₹3.22 Cr (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jan 20242010₹3.22 Cr (FY 2021)Active

Board colleagues of Parmjit Singh Walia

NameDINCompanyDesignation
Bhupinder Singh Walia10478414Yashu Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yashu Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Parmjit Singh Walia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parmjit Singh Walia

Parmjit Singh Walia currently holds 1 directorship: Yashu Pharmaceuticals Private Limited (Director, since 25 Jan 2024, revenue ₹3.22 Cr (FY 2021)).

Parmjit Singh Walia was first appointed on 25 Jan 2024 as Director at Yashu Pharmaceuticals Private Limited.

The current boards of Parmjit Singh Walia's companies include Bhupinder Singh Walia (Yashu Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available